SCHEMBL31700541

SCHEMBL31700541

O=[N+]([O-])c1cccc(S(=O)(=O)Nc2ccc3ocnc3c2)c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSPD1 P10809 2/20 0.64
▸ PTPN2 P17706 2/20 0.64
▸ PTPN1 P18031 2/20 0.64
▸ PTPN5 P54829 2/20 0.64
▸ HSPE1 P61604 2/20 0.64
▸ ALDH1A1 P00352 5/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ PGR P06401 1/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ FBP1 P09467 1/20 0.53
▸ MEN1 O00255 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ AR P10275 1/20 0.52
▸ TYMS P04818 1/20 0.51
▸ HIF1A Q16665 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31700862 0.88 HSPD1 (0.61) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31700702 0.81 PTPN5 (0.61) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31702052 0.81 PTPN2 (0.61) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31700542 0.81 PTPN2 (0.61) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31702160 0.81 HSPD1 (0.61) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL8311699 0.80 HSPD1 (0.62) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31700367 0.78 PTPN2 (0.64) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31701721 0.78 HSPD1 (0.64) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL8313260 0.78 L3MBTL1 (0.64) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL31701010 0.77 ALDH1A1 (0.60) PTPN2PTPN1PTPN5ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319056-A1 METHODS FOR TREATING CANCER UNIV INDIANA TRUSTEES (US) 2025-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319056-A1 METHODS FOR TREATING CANCER HSP90AB1, HSP90B1, HSP90AB2P HSPD1 13/4885PTPN2 2771/4885PTPN1 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback